Items related to The Pharmacology of Monoclonal Antibodies (Handbook...

The Pharmacology of Monoclonal Antibodies (Handbook of Experimental Pharmacology) - Softcover

 
9783642784347: The Pharmacology of Monoclonal Antibodies (Handbook of Experimental Pharmacology)
View all copies of this ISBN edition:
 
 
A sample of the most exciting developments in the cloning, manipulation, expression and application of genetically-engineered monoclonal antibodies. This rapidly-evolving field has witnessed the PCR combinatorial cloning of vast immunological diversity, in vitro mutagenesis of MAbs, MAbs created by transgenic animals, novel expression systems in plants, animals and lower systems, as well as a rich variety of genetically modified MAbs as potential therapeutic agents. Leading scientists from academia and industry present their own findings as well as short reviews of these research areas.

"synopsis" may belong to another edition of this title.

Other Popular Editions of the Same Title

9783540571230: The Pharmacology of Monoclonal Antibodies (Handbook of Experimental Pharmacology)

Featured Edition

ISBN 10:  354057123X ISBN 13:  9783540571230
Publisher: Springer, 1994
Hardcover

  • 9780387571232: Policy Innovation for Health (Handbook of Experimental Pharmacology)

    Springer, 2009
    Softcover

Top Search Results from the AbeBooks Marketplace

Seller Image

Published by Springer (2012)
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Soft Cover Quantity: 10
Seller:
booksXpress
(Bayonne, NJ, U.S.A.)

Book Description Soft Cover. Condition: new. Seller Inventory # 9783642784347

More information about this seller | Contact seller

Buy New
US$ 111.52
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2012)
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Softcover Quantity: > 20
Seller:
Lucky's Textbooks
(Dallas, TX, U.S.A.)

Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020236315

More information about this seller | Contact seller

Buy New
US$ 116.64
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds
Stock Image

R. Balint
Published by Springer (2012)
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Softcover Quantity: > 20
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)

Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783642784347_lsuk

More information about this seller | Contact seller

Buy New
US$ 124.04
Convert currency

Add to Basket

Shipping: US$ 12.48
From United Kingdom to U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2012)
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Softcover Quantity: 4
Seller:
Books Puddle
(New York, NY, U.S.A.)

Book Description Condition: New. pp. 438. Seller Inventory # 2648036916

More information about this seller | Contact seller

Buy New
US$ 138.40
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds
Seller Image

Martin Rosenberg
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Taschenbuch Quantity: 2
Print on Demand
Seller:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Germany)

Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -It has been almost 20 years since the discovery by Kohler and Milstein of the technology to produce monoclonal antibodies (MAbs), a discovery that promised revolutionary changes in research, clinical diagnosis and human therapy. From today's perspective, it is fair to conclude that this promise has been realized in two areas of the three. As research tools, MAbs have been invaluable: their ability to selectively bind and localize specific antigens, detect and identify new ligands and their receptors, and agonize and/or antagonize specific molecular interactions continues to provide a useful and enabling technology to basic research endeavors. Similarly, MAbs have demonstrated enormous practical impact as diagnostic tools. Recent advances in clinical diagnostic medicine continue to rely heavily on the use of MAb-based reagents for detecting and localizing antigens of clinical import. In contrast, however, MAbs have not proven to have major impact on human disease therapy. With the single exception of an immunosup pressive MAb against the T-cell antigen, CD3, MAbs have as yet found few meaningful applications as therapeutic agents. During the 1980s, a set of technologies to clone, modify and express genes encoding MAbs was developed. These breakthroughs permitted MAbs to be genetically engineered which consequently gave them the potential to greatly enhance their therapeutic utility as well as significantly expand their research and diagnostic applications. New MAbs, fragments of MAbs, bispecific MAbs, single-chain MAbs, and fusions of MAbs with other gene products became available for study. 436 pp. Englisch. Seller Inventory # 9783642784347

More information about this seller | Contact seller

Buy New
US$ 118.21
Convert currency

Add to Basket

Shipping: US$ 24.67
From Germany to U.S.A.
Destination, rates & speeds
Seller Image

Rosenberg, Martin|Moore, Gordon P.|Balint, R.|Barbas, C. F.|Blumenthal, R. D.|Carter, P.|Chatterjee, M.|Chen, Y.-C.Jack|Conry, R. M.|Foon, K. A.|Goldenberg, D. M.|Haber, E.|Hein, M.|Hiatt, A.|James, K.|Janda, K. D.|Karjalainen, K.|Kohler, H.|Larrick, J. W
Published by Springer Berlin Heidelberg (2012)
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Softcover Quantity: > 20
Print on Demand
Seller:
moluna
(Greven, Germany)

Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A sample of the most exciting developments in the cloning, manipulation, expression and application of genetically-engineered monoclonal antibodies. This rapidly-evolving field has witnessed the PCR combinatorial cloning of vast immunological diversity, in . Seller Inventory # 5070563

More information about this seller | Contact seller

Buy New
US$ 101.95
Convert currency

Add to Basket

Shipping: US$ 52.55
From Germany to U.S.A.
Destination, rates & speeds
Seller Image

Martin Rosenberg
Published by Springer Berlin Heidelberg (2012)
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Taschenbuch Quantity: 1
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)

Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - It has been almost 20 years since the discovery by Kohler and Milstein of the technology to produce monoclonal antibodies (MAbs), a discovery that promised revolutionary changes in research, clinical diagnosis and human therapy. From today's perspective, it is fair to conclude that this promise has been realized in two areas of the three. As research tools, MAbs have been invaluable: their ability to selectively bind and localize specific antigens, detect and identify new ligands and their receptors, and agonize and/or antagonize specific molecular interactions continues to provide a useful and enabling technology to basic research endeavors. Similarly, MAbs have demonstrated enormous practical impact as diagnostic tools. Recent advances in clinical diagnostic medicine continue to rely heavily on the use of MAb-based reagents for detecting and localizing antigens of clinical import. In contrast, however, MAbs have not proven to have major impact on human disease therapy. With the single exception of an immunosup pressive MAb against the T-cell antigen, CD3, MAbs have as yet found few meaningful applications as therapeutic agents. During the 1980s, a set of technologies to clone, modify and express genes encoding MAbs was developed. These breakthroughs permitted MAbs to be genetically engineered which consequently gave them the potential to greatly enhance their therapeutic utility as well as significantly expand their research and diagnostic applications. New MAbs, fragments of MAbs, bispecific MAbs, single-chain MAbs, and fusions of MAbs with other gene products became available for study. Seller Inventory # 9783642784347

More information about this seller | Contact seller

Buy New
US$ 122.72
Convert currency

Add to Basket

Shipping: US$ 35.39
From Germany to U.S.A.
Destination, rates & speeds
Stock Image

Published by Springer (2012)
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Softcover Quantity: 4
Print on Demand
Seller:
Majestic Books
(Hounslow, United Kingdom)

Book Description Condition: New. Print on Demand pp. 438 78 Figures, 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam. Seller Inventory # 44778475

More information about this seller | Contact seller

Buy New
US$ 151.83
Convert currency

Add to Basket

Shipping: US$ 8.13
From United Kingdom to U.S.A.
Destination, rates & speeds
Stock Image

Rosenberg, Martin (Edited by)/ Moore, Gordon P. (Edited by)/ Balint, R. (Contributions by)/ Barbas, C.F. (Contributions by)/ Blumenthal, R.D. (Contributions by)/ Carter, P. (Contributions by)/ Chatterjee, M. (Contributions by)/ Chen, Y.-C.Jack (Contributions by)/ Conry, R.M. (Contributions by)/ Foon, K.A. (Contributions by)/ Goldenberg, D.M. (Contributions by)/ Haber, E. (Contributions by)/ Hei
Published by Springer (2012)
ISBN 10: 3642784348 ISBN 13: 9783642784347
New Paperback Quantity: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)

Book Description Paperback. Condition: Brand New. reprint edition. 427 pages. 9.25x6.10x1.00 inches. In Stock. Seller Inventory # x-3642784348

More information about this seller | Contact seller

Buy New
US$ 149.36
Convert currency

Add to Basket

Shipping: US$ 12.51
From United Kingdom to U.S.A.
Destination, rates & speeds